Lynx Biosciences, Inc.

Medtech · Still private

Ex vivo microfluidic platform (MicroC) that analyzes patient multiple myeloma cell therapeutic response to drugs in coculture with bone marrow microenvironmental cells

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Total capital
$868K
Federal grants
$868K
3 awards · 2016–2017
Rank in peer group#43 of 542
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
1 pending · first 2018
Rank in peer group#106 of 542

Capital timeline

20162017FEDERAL ↑EQUITY ↓Cumulative $868K$269K$300K$300K
20162017FEDERAL ↑EQUITY ↓Cumulative $868K$269K$300K$300K

Latest events

  • Federal grantHealth and Human S · Phase I · Automation of MicroC as a CDx for myeloma therapies$300K
  • Federal grantHealth and Human S · Phase I · Automation of MicroC3 as a CDx for myeloma therapies$300K
  • Federal grantHealth and Human S · Phase I · Microfluidic assay to predict patient-specific multiple myeloma clinical response$269K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 542 peers

Line = median

Medtech · Device

  • Federal grants#43 · top 8%
  • Granted patents#106 · top 20%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 2
  • DELGEN BIOSCIENCES INCSimilar federal contract value in Medtech · null in contracts
  • Wyatt's JV, LLCSimilar federal contract value in Medtech · null in contracts
  • HARBOR MEDTECH, INC.Similar federal contract value in Medtech · null in contracts
  • ASCAN LLCSimilar federal contract value in Medtech · null in contracts
  • My Music Machines Inc.Similar federal contract value in Medtech · null in contracts
  • Cardiac Motion, LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .